<DOC>
	<DOCNO>NCT00765713</DOCNO>
	<brief_summary>Hypothesis : The CPAP treatment diminishes effect ventricular arrhythmia patient ischemic heart disease dilate myocardiopathy , systolic ventricular disfunction sleep apnea-hypopnea syndrome ( SAHS ) Objectives : To analyze incidence ventricular arrhythmia ( premature ventricular beat , non-sustained ventricular tachycardia sustain ventricular tachycardia ) appropriate defibrillator therapy patient ischemic heart disease dilate myocardiopathy , moderate-severe leave ventricular dysfunction , implantable cardioverter-defibrillator ( ICD ) sleep apnea . To study effect CPAP cardiac arrhythmia number appropriate defibrillator therapy . Design : Parallel , randomize single-blinded multicentric study compare CPAP vs. hygienic-dietetic recommendation . Patients SAHS ( AHIâ‰¥15 ) systolic leave ventricle dysfunction patient ICD . Duration : 24 month .</brief_summary>
	<brief_title>Sleep Apnea-hypopnea Syndrome ( SAHS ) Ventricular Arrhythmias</brief_title>
	<detailed_description>Secondary objective : To compare prevalence SAHS patient ischemic heart disease dilate myocardiopathy moderate-severe left ventricle dysfunction ICD general population . To study incidence supraventricular arrhythmia ( atrial fibrillation , atrial flutter supraventricular tachycardia ) inappropriate defibrillator therapies patient . To value effect treatment CPAP mention arrhythmias . To relate effect ventricular supraventricular arrhythmia sleep parameter , cardiovascular biomarkers , inflammation oxidative stress . To evaluate long-term effect CPAP systemic biomarkers patient ischemic heart disease dilate myocardiopathy moderate-severe left ventricle dysfunction . To evaluate long-term effect CPAP quality life patient . Sample size : 224 patient ischemic heart disease dilate myocardiopathy moderate-severe left ventricle dysfunction ICD include randomize 19 SAHS subject arm .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Previous diagnostic ischaemic heart disease dilate myocardiopathy Ejection fraction leave ventricle &lt; 40 % Patients implantable cardioverterdefibrillator Diurnal hypersomnolence EES &gt; 16 Morbid obesity ( BMI &gt; 35 Kg/m2 ) . Moderatesevere chronic obstructive pulmonary disease ( FEV1/FVC &lt; 70 % FEV1 &lt; 80 % reference ) . Known thyroid disease . Previous treatment CPAP .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Sleep apnea</keyword>
	<keyword>CPAP</keyword>
	<keyword>Ventricular arrhythmia</keyword>
	<keyword>Defibrillator therapy</keyword>
</DOC>